Contract Notice Detail

Summary Information

Summary Information
4,820.635000 Euro
 
ULS S. José 51036124 
MEDICAMENTOS DIVERSOS DO AQ2023/492 
Tendering Phase
Awarded
AMOXICILINA 125 MG/5 ML + ÁCIDO CLAVULÂNICO 31.25 MG/5 ML PÓ SUSP ORAL FR 120 ML;PIRIMETAMINA 25 MG COMP; AZTREONAM 75 MG/1 ML PÓ SOL INAL NEB FR 1 ML INALATÓRIA; CEFTRIAXONA 1000 MG PÓ SOL INJ FR IM; CEFUROXIMA 250 MG/5 ML PÓ SUSP ORAL FR 100 ML 
VortalGOV - Acquisition under a Framework Agreement (via Direct Award) 
Lot NameLot Base PriceExpected Duration
A468 - AMOXICILINA + ÁCIDO CLAVULANICO (susp.oral) [125 MG/5 ML + 31,25 MG/ 5ML; FRS]-177 (Days)
P383 - PIRIMETAMINA [25 MG; CÁP/COMP]-177 (Days)
A5113 - AZTREONAM (pó sol inal neb) [75 MG/1 ML; FRS]-177 (Days)
C126 - CEFTRIAXONA [1G; IM; F/AMP]-177 (Days)
C132 - CEFUROXIMA (pó p/a susp. oral) [25 MG/ML; FRS]-177 (Days)

Object of the Contract

Object of the Contract
Supplies Acquisition 
Rua José António Serrano 1150-199 Arroios Lisboa PORTUGAL  
33600000-6 - Pharmaceutical products
 
 
 

Scheduling

Scheduling
7/9/2024 12:03 PM (UTC +1 hour)
 
7/26/2023 11:45 AM (UTC +1 hour)
 
7/12/2024 4:30 PM (UTC +1 hour)
 

Financial Settings

Financial Settings
No 

Contract Documents

Contract Documents
Document NameDescriptionDoc Classification
Convite.pdfConvite.pdfDownload

Object of contract

No 
No 

Legal, economic, financial and technical information

No 

Questionnaire

Questionnaire
1
Lot Title
A468 - AMOXICILINA + ÁCIDO CLAVULANICO (susp.oral) [125 MG/5 ML + 31,25 MG/ 5ML; FRS]
Base Price
50,000000

1.1   Bill of Quantities  *  
This price list has extra requirements. Make sure everything is completed, under each article line.

Item Code Description Quantity Unit
10004851 AMOXICILINA + ÁCIDO CLAVULANICO (susp.oral) [125 MG/5 ML + 31,25 MG/ 5ML; FRS] A468 40,000000 NXTWY.UMT.17648
Buyer Comment: 500139962 | GlaxoSmithKline - Produtos Farmacêuticos, Lda. | CPA:2023492/68/0020 | NºAIM:8605014; 506985261 | Sandoz Farmacêutica, Lda. | CPA:2023492/326/0212 | NºAIM:2563088;
TOTAL (The amounts shown do not include VAT)
2
Lot Title
P383 - PIRIMETAMINA [25 MG; CÁP/COMP]
Base Price
361,200000

2.1   Bill of Quantities  *  
This price list has extra requirements. Make sure everything is completed, under each article line.

Item Code Description Quantity Unit
10075001 PIRIMETAMINA [25 MG; CÁP/COMP] P383 400,000000 NXTWY.UMT.17648
Buyer Comment: 501169580 | Labesfal - Laboratórios Almiro, S.A. | CPA:2023492/107/0159 | NºAIM:5012539;
TOTAL (The amounts shown do not include VAT)
3
Lot Title
A5113 - AZTREONAM (pó sol inal neb) [75 MG/1 ML; FRS]
Base Price
391,935000

3.1   Bill of Quantities  *  
This price list has extra requirements. Make sure everything is completed, under each article line.

Item Code Description Quantity Unit
10099148 AZTREONAM (pó sol inal neb) [75 MG/1 ML; FRS] A5113 17,000000 NXTWY.UMT.17648
Buyer Comment: 503604704 | Gilead Sciences, Lda. | CPA:2023492/229/0030 | NºAIM:5277314;
TOTAL (The amounts shown do not include VAT)
4
Lot Title
C126 - CEFTRIAXONA [1G; IM; F/AMP]
Base Price
3 696,000000

4.1   Bill of Quantities  *  
This price list has extra requirements. Make sure everything is completed, under each article line.

Item Code Description Quantity Unit
10031970 CEFTRIAXONA [1G; IM; F/AMP] C126 1 600,000000 NXTWY.UMT.17648
Buyer Comment: 504293753 | Fresenius Kabi Pharma Portugal, Lda. | CPA:2023492/51/0195 | NºAIM:5585922; 505792362 | Overpharma, Produtos Médicos e Farmacêuticos, Lda. | CPA:2023492/247/0182 | NºAIM:5335146;
TOTAL (The amounts shown do not include VAT)
5
Lot Title
C132 - CEFUROXIMA (pó p/a susp. oral) [25 MG/ML; FRS]
Base Price
321,500000

5.1   Bill of Quantities  *  
This price list has extra requirements. Make sure everything is completed, under each article line.

Item Code Description Quantity Unit
10026837 CEFUROXIMA (pó p/a susp. oral) [25 MG/ML; FRS] C132 50,000000 NXTWY.UMT.17648
Buyer Comment: 506985261 | Sandoz Farmacêutica, Lda. | CPA:2023492/326/0344 | NºAIM:8780700;
TOTAL (The amounts shown do not include VAT)

Evaluation

Evaluation
Vision

Avaliação

Definir modelo de avaliação
Modalidade de avaliação
Método de Avaliação
Divulgar critérios de avaliação

Critérios da Avaliação

1 - A468 - AMOXICILINA + ÁCIDO CLAVULANICO (susp.oral) [125 MG/5 ML + 31,25 MG/ 5ML; FRS]

Critérios da Avaliação

Descrição
Tipo de Fator
Peso (%)
1.PricePreço100%

Normas de desempate

Definir normas de desempate?

2 - P383 - PIRIMETAMINA [25 MG; CÁP/COMP]

Critérios da Avaliação

Descrição
Tipo de Fator
Peso (%)
1.PricePreço100%

Normas de desempate

3 - A5113 - AZTREONAM (pó sol inal neb) [75 MG/1 ML; FRS]

Critérios da Avaliação

Descrição
Tipo de Fator
Peso (%)
1.PricePreço100%

Normas de desempate

4 - C126 - CEFTRIAXONA [1G; IM; F/AMP]

Critérios da Avaliação

Descrição
Tipo de Fator
Peso (%)
1.PricePreço100%

Normas de desempate

5 - C132 - CEFUROXIMA (pó p/a susp. oral) [25 MG/ML; FRS]

Critérios da Avaliação

Descrição
Tipo de Fator
Peso (%)
1.PricePreço100%

Normas de desempate

Public Messages

Public Messages
TypeReferenceSubjectDate
No items found...